Artificial ‘cells’ boost the immune response to cancer
Biomedical engineers from Yale University have created artificial cells, which can considerably increase production of T-lymphocytes, responsible for immune response. Their application allows to stimulate an organism of the patient to struggle against cancer, and also certain infectious diseases, informs magazine Molecular Therapy.
Artificial cells have been created by Tarek Fahmy and Erin Steenblock. These cells were made from a substance of natural origin, which is used in manufacture of absorbable suture material and approved by FDA.
Use of artificial cells allows to simulate natural process of proliferation and stimulations of T-lymphocytes, in particular cytotoxic T-lymphocytes, vital in destruction of cancer cells. However this process accelerates and proceeds more effectively, has noted Fahmy.